NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 8 min ago
Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (Parent R01 Clinical Trial Not Allowed)
Notice NOT-HL-19-712 from the NIH Guide for Grants and Contracts
Notice NOT-AA-19-021 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-19-003 from the NIH Guide for Grants and Contracts. NIEHS invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response. This funding opportunity announcement aims to prevent work-related harm through safety and health training. The training programs will transmit skills and knowledge to workers in how best to protect themselves and their communities from exposure to hazardous materials encountered during hazardous waste operations, hazardous materials transportation, environmental restoration of contaminated facilities or chemical emergency response. A variety of sites, such as those involved with chemical waste cleanup and remedial action and transportation-related chemical emergency response, may pose severe health and safety concerns to workers and the surrounding communities. These sites contain many hazardous substances, sometimes unknown, and often a site is uncontrolled. A major goal of the Worker Training Program (WTP) is to support institutional competency-building for the development and delivery of model training and education programs.
Notice of Intent to Publish Reissuance of RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Notice NOT-OD-19-130 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-132 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-19-004 from the NIH Guide for Grants and Contracts. The purpose of the NIEHS/DOE Nuclear Worker Training Program is to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response within the DOE nuclear weapons complex.
Notice of NCCIH's Withdrawal from Participation in PAR-18-494, "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)"
Notice NOT-AT-19-033 from the NIH Guide for Grants and Contracts
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-19-343 from the NIH Guide for Grants and Contracts. The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the basic biomedical sciences research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of outstanding postdoctoral researchers from diverse backgrounds (e.g., see NIHs Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions at research-intensive institutions. The MOSAIC K99/R00 program will provide independent NIH research support during this transition to help awardees launch competitive, independent research careers. Additionally, MOSAIC K99/R00 scholars will be part of organized scientific cohorts that will be expected to participate in mentoring, networking, and professional development activities coordinated by MOSAIC Institutionally-Focused Research Education Award to Promote Diversity (UE5) grantees.
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
Funding Opportunity PAR-19-342 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (UE5) supports research education activities in the mission areas of the NIH. The over-arching goal of the MOSAIC UE5 program is to support educational activities that encourage individuals from diverse backgrounds, for example those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development and Mentoring Activities. Applications are encouraged from organizations of biomedical researchers (e.g., scientific societies) with a membership of scientists conducting research within the mission of NIH, experience serving as a centralized entity to enhance scientific communication and networking among scientists conducting research, an established record of providing professional development and networking activities for the next generation of biomedical researchers, and a demonstrated commitment to enhancing the diversity of the biomedical research workforce. The program provides support for well-designed courses for skills development and mentoring activities to prepare MOSAIC K99/R00 grantees to transition into, succeed, and advance in independent faculty careers at research-intensive institutions.
Notice NOT-DA-19-065 from the NIH Guide for Grants and Contracts
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-HL-20-030 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans. Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-344 from the NIH Guide for Grants and Contracts. EXplainable Artificial Intelligence (XAI) aims to provide strong predictive value along with mechanistic understanding by combining machine learning techniques with effective explanatory techniques. This Funding Opportunity Announcement (FOA) solicits applications in the area of XAI applied to neuroscientific questions of encoding, decoding, and modulation of neural circuits linked to behavior. This FOA encourages collaborations between computationally and experimentally-focused investigators. This FOA seeks machine learning algorithms able to mechanistically explain how experimental manipulations can improve cognitive, affective, or social processing in humans or animals. Proof-of-concept applications aimed at improving the current state of the technology that use XAI to provide unbiased, hierarchical explanations of causal relationships between complex neural and behavioral data are also responsive.
Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-031 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support short courses geared to behavioral and social scientists who have existing expertise in aging research and can make research contributions in Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) with additional knowledge about the diseaseand related research resources. Fields of behavioral and social science research relevant for this FOA are health economics, labor economics, health services research, healthcare policy, public policy, demography, sociology, social epidemiology, psychology, and social neuroscience. Priority areas of focus include, but are not limited to, the following: dementia care; dementia caregiver research; cognitive and dementia epidemiology; behavioral and social pathways of AD/ADRD; role of social, contextual, environmental, and institutional factors in AD/ADRD; early psychological changes preceding AD/ADRD onset; prevention of AD/ADRD; disparities in AD/ADRD or dementia-related outcomes; and research resources and methods for studying the determinants and impact of AD/ADRD.
Notice to Extend PAR-18-113, Center of Excellence for Research on Complementary and Integrative Health (P01, Clinical Trial Optional)
Notice NOT-AT-19-032 from the NIH Guide for Grants and Contracts
Notice of Correction to the Companion Program Announcement Cited in PA-19-118, Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
Notice NOT-OD-19-134 from the NIH Guide for Grants and Contracts
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-015, "Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)"
Notice NOT-HL-19-717 from the NIH Guide for Grants and Contracts
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-017, "Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)"
Notice NOT-HL-19-716 from the NIH Guide for Grants and Contracts
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
Funding Opportunity PAR-19-339 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-340 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimers Disease
Notice NOT-AG-19-033 from the NIH Guide for Grants and Contracts
NIH Funding Opportunities
- Notice of NIAAA's Participation in PAR-19-162 "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) "
- NIH Announces New Centralized Notifications for Unfunded Applications
- Request for Information (RFI): Strategies to Support Acquisition and Use of Biospecimens for Research on Sepsis in Humans
- Notice of NIAAA's Participation in PAR-19-163 "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)"
- Notice to Extend the Expiration Date for PAR-18-645 "Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)"